261 related articles for article (PubMed ID: 27873266)
1. Establishment of EBV-Infected Lymphoblastoid Cell Lines.
Nagy N
Methods Mol Biol; 2017; 1532():57-64. PubMed ID: 27873266
[TBL] [Abstract][Full Text] [Related]
2. Establishment of Epstein-Barr virus growth-transformed lymphoblastoid cell lines.
Hui-Yuen J; McAllister S; Koganti S; Hill E; Bhaduri-McIntosh S
J Vis Exp; 2011 Nov; (57):. PubMed ID: 22090023
[TBL] [Abstract][Full Text] [Related]
3. Immortalized Epstein-Barr virus-positive B-cell lines obtained by prolonged culture of peripheral blood mononuclear cells from human immunodeficiency virus type 1-positive patients.
Ruibal-Ares B; Belmonte L; Baré P; Scolnik M; Palacios MF; Bayo-Hanza C; Galmarini CM; Mendez G; de Bracco MM
J Hum Virol; 2001; 4(4):200-13. PubMed ID: 11694848
[TBL] [Abstract][Full Text] [Related]
4. Effect of Interleukins on Antibody Production by Epstein-Barr Virus Transformed B Cells.
Ali AI; Badran YR; Hassuneh MR; Sanber KS; Ismail SI
Monoclon Antib Immunodiagn Immunother; 2015 Jun; 34(3):162-8. PubMed ID: 26090593
[TBL] [Abstract][Full Text] [Related]
5. Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus.
Sugimoto M; Tahara H; Ide T; Furuichi Y
Cancer Res; 2004 May; 64(10):3361-4. PubMed ID: 15150084
[TBL] [Abstract][Full Text] [Related]
6. Early gene expression changes by Epstein-Barr virus infection of B-cells indicate CDKs and survivin as therapeutic targets for post-transplant lymphoproliferative diseases.
Bernasconi M; Ueda S; Krukowski P; Bornhauser BC; Ladell K; Dorner M; Sigrist JA; Campidelli C; Aslandogmus R; Alessi D; Berger C; Pileri SA; Speck RF; Nadal D
Int J Cancer; 2013 Nov; 133(10):2341-50. PubMed ID: 23640782
[TBL] [Abstract][Full Text] [Related]
7. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
8. Immune activation suppresses initiation of lytic Epstein-Barr virus infection.
Ladell K; Dorner M; Zauner L; Berger C; Zucol F; Bernasconi M; Niggli FK; Speck RF; Nadal D
Cell Microbiol; 2007 Aug; 9(8):2055-69. PubMed ID: 17419714
[TBL] [Abstract][Full Text] [Related]
9. Propagation of EBV-driven Lymphomatous Transformation of Peripheral Blood B Cells by Immunomodulators and Biologics Used in the Treatment of Inflammatory Bowel Disease.
Levhar N; Ungar B; Kopylov U; Fudim E; Yavzori M; Picard O; Amariglio N; Chowers Y; Shemer-Avni Y; Mao R; Chen MH; Ye Z; Eliakim R; Ben-Horin S
Inflamm Bowel Dis; 2020 Aug; 26(9):1330-1339. PubMed ID: 32322878
[TBL] [Abstract][Full Text] [Related]
10. Glycoprotein 110, the Epstein-Barr virus homolog of herpes simplex virus glycoprotein B, is essential for Epstein-Barr virus replication in vivo.
Herrold RE; Marchini A; Fruehling S; Longnecker R
J Virol; 1996 Mar; 70(3):2049-54. PubMed ID: 8627735
[TBL] [Abstract][Full Text] [Related]
11. STAT1 contributes to the maintenance of the latency III viral programme observed in Epstein-Barr virus-transformed B cells and their recognition by CD8+ T cells.
McLaren JE; Zuo J; Grimstead J; Poghosyan Z; Bell AI; Rowe M; Brennan P
J Gen Virol; 2009 Sep; 90(Pt 9):2239-50. PubMed ID: 19439556
[TBL] [Abstract][Full Text] [Related]
12. Signatures of B-cell receptor diversity in B lymphocytes following Epstein-Barr virus transformation.
Lai M; Wang Q; Lu Y; Xu X; Xia Y; Tu M; Liu Y; Zhang Q; Peng Y; Zheng X
Physiol Genomics; 2019 Jun; 51(6):197-207. PubMed ID: 31002588
[TBL] [Abstract][Full Text] [Related]
13. Host genetic variants and gene expression patterns associated with Epstein-Barr virus copy number in lymphoblastoid cell lines.
Houldcroft CJ; Petrova V; Liu JZ; Frampton D; Anderson CA; Gall A; Kellam P
PLoS One; 2014; 9(10):e108384. PubMed ID: 25290448
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of Epstein-Barr virus transformed B cell lines from patients with Alzheimer's disease and age-matched controls.
Ounanian A; Guilbert B; Seigneurin JM
Mech Ageing Dev; 1992 Mar; 63(1):105-16. PubMed ID: 1318479
[TBL] [Abstract][Full Text] [Related]
15. Identification of tumor necrosis factor signaling-related proteins during Epstein-Barr virus-induced B cell transformation.
Jeon JP; Kim JW; Park B; Nam HY; Shim SM; Lee MH; Han BG
Acta Virol; 2008; 52(3):151-9. PubMed ID: 18999889
[TBL] [Abstract][Full Text] [Related]
16. Generation of lymphoblastoid cell lines (LCLs).
Frisan T; Levitsky V; Masucci M
Methods Mol Biol; 2001; 174():125-7. PubMed ID: 11357634
[No Abstract] [Full Text] [Related]
17. Induction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines.
Skalska L; White RE; Parker GA; Turro E; Sinclair AJ; Paschos K; Allday MJ
PLoS Pathog; 2013 Feb; 9(2):e1003187. PubMed ID: 23436997
[TBL] [Abstract][Full Text] [Related]
18. Whole-exome sequencing of DNA from peripheral blood mononuclear cells (PBMC) and EBV-transformed lymphocytes from the same donor.
Londin ER; Keller MA; D'Andrea MR; Delgrosso K; Ertel A; Surrey S; Fortina P
BMC Genomics; 2011 Sep; 12():464. PubMed ID: 21943378
[TBL] [Abstract][Full Text] [Related]
19. The viral and cellular microRNA targetome in lymphoblastoid cell lines.
Skalsky RL; Corcoran DL; Gottwein E; Frank CL; Kang D; Hafner M; Nusbaum JD; Feederle R; Delecluse HJ; Luftig MA; Tuschl T; Ohler U; Cullen BR
PLoS Pathog; 2012 Jan; 8(1):e1002484. PubMed ID: 22291592
[TBL] [Abstract][Full Text] [Related]
20. Sustained viral activity of epstein-Barr virus contributes to cellular immortalization of lymphoblastoid cell lines.
Jeon JP; Nam HY; Shim SM; Han BG
Mol Cells; 2009 Feb; 27(2):143-8. PubMed ID: 19277495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
